Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults

NCT03732638 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1590

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Rimegepant
DRUG: Placebo

Sponsor

Pfizer